Infliximab for Injection
Efficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.
The first infliximab biosimilar marketed in China
Infliximab for Injection (Reminton), a recombinant anti-TNF-alpha chimeric monoclonal antibody, was approved for marketing by the National Medical Products Administration (NMPA) on July 14, 2021. It is the first infliximab biosimilar marketed in China. Taking advantage of CHO cell expression system, Remin_x005f ton has been proved with good efficacy, better safety, and lower immunogenicity in clinical studies.
Indications:
Crohn's disease in adults and children over 6 years of age, stulizing Crohn's disease,
ulcerative colitis in adults, ankylosing spondylitis, rheumatoid arthritis, and psoriasis.
Recommended reading
Related products
-
Quick View
The Benefits of Roof Insulation: Is it a Wise Investment?
Read moreRoof insulation is a topic that often goes unnoticed, yet it plays a crucial role in maintaining a comfortable and energy-efficient home. Many homeowners wonder whether insulating their roof is a good idea. In this article, we will delve into the benefits of roof insulation, exploring its impact on energy efficiency, cost savings, and overall …
The Benefits of Roof Insulation: Is it a Wise Investment?Read More
-
Quick View
Quisque mi est, blandit sed maximus
Original price was: $63.00.$57.00Current price is: $57.00.Add to cartDuis feugiat sapien et augue dignissim porta. Nullam magna velit, laoreet porta vestibulum nec, auctor sed dui. Integer ac sodales enim. Quisque magna est, mollis euismod nibh in, elementum congue orci. Cras viverra, elit vitae iaculis efficitur, turpis urna sodales eros, vel finibus lacus elit sit amet dolor. Praesent at erat in purus pretium laoreet.
-
Quick View
Pellentesque dignissim sapien semper
$78.00Add to cartCras luctus ultricies ex luctus malesuada. Fusce imperdiet interdum consectetur. Pellentesque dignissim sapien semper consequat sollicitudin. Phasellus iaculis libero ac placerat aliquam. Etiam a velit eu diam consequat vestibulum. Ut a malesuada nulla. Vivamus quis maximus nisi, vel molestie sapien. Nunc pharetra finibus elit sed consectetur.
-
Quick View
Curabitur ultricies ante ultricies blandit
$88.00Add to cartCurabitur ultricies ante ultricies blandit placerat. Phasellus fermentum, ligula sed vestibulum blandit, mi odio laoreet sem, a venenatis tellus felis eu justo. Nullam ut felis et mauris iaculis malesuada. Donec non turpis vel lectus accumsan rutrum. Vestibulum finibus nunc libero, vel dapibus mauris porta vitae.
Reviews
There are no reviews yet.